ArticleEmerging infectious diseases2004
SARS molecular detection external quality assurance.
Article in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020Article
- Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA.Annals of laboratory medicine · 2017Article
- Assay optimization for molecular detection of Zika virus.Bulletin of the World Health Organization · 2016Article
- Clinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics.Expert review of molecular diagnostics · 2016Article
- Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2014Article
- Detection of respiratory viruses using a multiplex real-time PCR assay in Germany, 2009/10.Archives of virology · 2014Article
- Review
- Singleplex real-time RT-PCR for detection of influenza A virus and simultaneous differentiation of A/H1N1v and evaluation of the RealStar influenza kit.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2011Article
- Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor.Biosensors & bioelectronics · 2009Article
- Performance of the RealStar Chikungunya virus real-time reverse transcription-PCR kit.Journal of clinical microbiology · 2009Article
- Coordinated implementation of chikungunya virus reverse transcription-PCR.Emerging infectious diseases · 2009Article
- Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories.The Journal of infectious diseases · 2007Article
- First international proficiency study on West Nile virus molecular detection.Clinical chemistry · 2006Article
- Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain.Clinical chemistry · 2006Article
- Follow-up on diagnostic proficiency of laboratories equipped to perform orthopoxvirus detection and quantification by PCR: the second international external quality assurance study.Journal of clinical microbiology · 2006Article
- Automated extraction protocol for quantification of SARS-coronavirus RNA in serum: an evaluation study.BMC infectious diseases · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inactivated severe acute respiratory syndrome-associated coronavirus samples were used for an external quality assurance study within the World Health Organization SARS Reference and Verification Network and other reference institutions. Of 58 participants, 51 correctly detected virus in all samples > or =9,400 RNA copies per milliliter and none in negative samples. Commercial test kits significantly improved the outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.